Back
Also listed as
CMXHF
OTC
Day Range
$24.44
$24.68
52-Week Range
$22.83
$44.86
Volume
19,243
50D / 200D Avg
$27.97
/
$33.31
Prev Close
$24.36
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 31.7 | 0.2 |
| P/B | 4.9 | 3.0 |
| ROE % | 16.4 | 3.6 |
| Net Margin % | 19.5 | 3.8 |
| Rev Growth 5Y % | 10.7 | 9.9 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
Hold
$307.00
+1148.5%
Forward P/E
7.00
Forward EPS
$3.48
EPS Growth (est.)
+0.0%
Est. Revenue
16.28B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$1.95
$1.91 – $1.98
|
17.00B | 1 |
| FY2026 |
$3.48
$3.40 – $3.53
|
16.28B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | N/A | $0.10 | — |
| 2025-02-11 | N/A | $0.52 | — |
| 2024-10-30 | N/A | $2.03 | — |
| 2024-08-13 | N/A | $0.19 | — |
| 2024-04-11 | N/A | $0.51 | — |
| 2024-02-13 | N/A | $1.95 | — |
| 2023-06-30 | N/A | $0.15 | — |
| 2023-03-31 | N/A | $0.59 | — |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.48%
Growth (3Y)
9.57%
Growth (5Y)
7.93%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 11, 2026 | Apr 16, 2026 | $0.33 | 2.88% |
| Sep 10, 2025 | Oct 10, 2025 | $0.81 | 2.10% |
| Mar 11, 2025 | Apr 16, 2025 | $0.65 | 1.75% |
| Sep 10, 2024 | Oct 09, 2024 | $0.73 | 1.31% |
| Mar 11, 2024 | Apr 10, 2024 | $0.60 | 1.34% |
| Sep 08, 2023 | Oct 10, 2023 | $0.65 | 1.37% |
| Mar 08, 2023 | Apr 11, 2023 | $0.54 | 1.15% |
| Sep 02, 2022 | Oct 11, 2022 | $0.59 | 1.10% |
| Mar 04, 2022 | Apr 11, 2022 | $0.52 | 1.16% |
| Sep 01, 2021 | Oct 05, 2021 | $0.59 | 0.98% |
| Mar 03, 2021 | Apr 06, 2021 | $0.52 | 1.02% |
| Sep 09, 2020 | Oct 19, 2020 | $0.54 | 0.98% |
| Mar 10, 2020 | Apr 20, 2020 | $0.46 | 0.96% |
| Sep 09, 2019 | Oct 21, 2019 | $0.49 | 1.12% |
| Mar 14, 2019 | Apr 22, 2019 | $0.43 | 1.28% |
| Sep 10, 2018 | Oct 22, 2018 | $0.45 | 1.14% |
| Mar 13, 2018 | Apr 23, 2018 | $0.39 | 1.17% |
| Sep 11, 2017 | Oct 23, 2017 | $0.36 | 1.27% |
| Mar 13, 2017 | Apr 24, 2017 | $0.32 | 1.39% |
| Sep 09, 2016 | Oct 17, 2016 | $0.34 | 1.65% |
Key Takeaways
Revenue grew 10.73% annually over 5 years — strong growth
ROE of 16.36% — decent returns on equity
Net margin of 19.46% shows strong profitability
Generating 2.54B in free cash flow
P/E of 31.72 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.47%
Growth
Revenue Growth (5Y)
10.73%
Revenue (1Y)4.26%
Earnings (1Y)13.63%
FCF Growth (3Y)67.29%
Quality
Return on Equity
16.36%
ROIC7.20%
Net Margin19.46%
Op. Margin19.18%
Safety
Debt / Equity
0.59
Current Ratio2.46
Interest Coverage6.51
Valuation
P/E Ratio
31.72
Forward P/E7.00
P/B Ratio4.92
EV/EBITDA35.34
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.26% | Revenue Growth (3Y) | 8.22% |
| Earnings Growth (1Y) | 13.63% | Earnings Growth (3Y) | 16.97% |
| Revenue Growth (5Y) | 10.73% | Earnings Growth (5Y) | 13.91% |
| Profitability | |||
| Revenue (TTM) | 15.43B | Net Income (TTM) | 3.00B |
| ROE | 16.36% | ROA | 7.62% |
| Gross Margin | 51.53% | Operating Margin | 19.18% |
| Net Margin | 19.46% | Free Cash Flow (TTM) | 2.54B |
| ROIC | 7.20% | FCF Growth (3Y) | 67.29% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 2.46 |
| Interest Coverage | 6.51 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.48% |
| Dividend Growth (3Y) | 9.57% | Dividend Growth (5Y) | 7.93% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 31.72 | Forward P/E | 7.00 |
| P/B Ratio | 4.92 | P/S Ratio | 6.17 |
| PEG Ratio | 3.83 | Forward PEG | N/A |
| EV/EBITDA | 35.34 | Fwd EV/EBITDA | 19.67 |
| Forward P/S | 5.85 | Fwd Earnings Yield | 14.29% |
| FCF Yield | 2.67% | ||
| Market Cap | 95.22B | Enterprise Value | 104.56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15.43B | 14.80B | 13.17B | 10.49B | 10.27B |
| Net Income | 3.00B | 2.64B | 2.19B | 2.25B | 1.78B |
| EPS (Diluted) | 0.39 | 0.34 | 0.43 | 0.30 | 0.33 |
| Gross Profit | 7.95B | 7.56B | 6.71B | 5.66B | 5.74B |
| Operating Income | 2.96B | 3.81B | 2.90B | 2.92B | 2.59B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 39.40B | 38.02B | 36.23B | 28.35B | 13.63B |
| Total Liabilities | 18.00B | 18.62B | 18.41B | 13.77B | 7.34B |
| Shareholders' Equity | 19.34B | 17.36B | 15.79B | 14.58B | 6.29B |
| Total Debt | 11.50B | 12.18B | 12.23B | 9.66B | 4.36B |
| Cash & Equivalents | 2.16B | 1.66B | 1.55B | 10.44B | 1.36B |
| Current Assets | 11.85B | 10.77B | 9.26B | 16.46B | 5.55B |
| Current Liabilities | 4.81B | 4.95B | 4.61B | 7.11B | 2.33B |